首页> 美国卫生研究院文献>Autophagy >The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation
【2h】

The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation

机译:天然化合物oblongifolin C抑制自噬通量并增强营养剥夺的抗肿瘤功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Metabolic stress induces autophagy as an alternative source of energy and metabolites. Insufficient autophagy in nutrient-deprived cancer cells would be beneficial for cancer therapy. Here, we performed a functional screen in search of novel autophagy regulators from natural products. We showed that oblongifolin C (OC), a natural small molecule compound extracted from Garcinia yunnanensis Hu, is a potent autophagic flux inhibitor. Exposure to OC results in an increased number of autophagosomes and impaired degradation of SQSTM1/p62. Costaining of GFP-LC3B with LysoTracker Red or LAMP1 antibody demonstrates that autophagosome-lysosome fusion is blocked by OC treatment. Furthermore, OC inhibits lysosomal proteolytic activity by altering lysosomal acidification and downregulating the expression of lysosomal cathepsins. Importantly, OC can eliminate the tolerance of cancer cells to nutrient starvation. Starvation dramatically increases the susceptibility of cancer cells to OC-induced CASP3-dependent apoptosis in vitro. Subsequent studies in xenograft mouse model showed that OC has anticancer potency as revealed by increased staining of cleaved CASP3, LC3 puncta, and SQSTM1, as well as reduced expression of lysosomal cathepsins. Combined treatment with OC and caloric restriction potentiates anticancer efficacy of OC in vivo. Collectively, these data demonstrated that OC is a novel autophagic flux inhibitor and might be useful in anticancer therapy.
机译:代谢应激诱导自噬作为能量和代谢物的替代来源。营养缺乏的癌细胞中自噬不足会有益于癌症治疗。在这里,我们进行了功能筛选,以寻找来自天然产物的新型自噬调节剂。我们表明,从植物云南藤黄中提取的天然小分子化合物oblongifolin C(OC)是一种有效的自噬通量抑制剂。暴露于OC会导致自噬体数量增加和SQSTM1 / p62的降解受损。用LysoTracker Red或LAMP1抗体对GFP-LC3B进行隐性染色表明,OC处理可阻止自噬体-溶酶体融合。此外,OC通过改变溶酶体酸化和下调溶酶体组织蛋白酶的表达来抑制溶酶体蛋白水解活性。重要的是,OC可以消除癌细胞对营养缺乏的耐受性。饥饿极大地增加了癌细胞对体外OC诱导的CASP3依赖性细胞凋亡的敏感性。随后在异种移植小鼠模型中的研究表明,通过裂解的CASP3,LC3点和SQSTM1的染色增加以及溶酶体组织蛋白酶的表达降低,OC具有抗癌作用。 OC与热量限制的联合治疗可增强OC在体内的抗癌功效。这些数据共同表明,OC是一种新型的自噬通量抑制剂,可能在抗癌治疗中有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号